These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19363525

  • 1. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
    Cimmino F, Schulte JH, Zollo M, Koster J, Versteeg R, Iolascon A, Eggert A, Schramm A.
    Oncogene; 2009 May 14; 28(19):2015-23. PubMed ID: 19363525
    [Abstract] [Full Text] [Related]

  • 2. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
    Eggert A, Ikegaki N, Liu XG, Brodeur GM.
    Klin Padiatr; 2000 May 14; 212(4):200-5. PubMed ID: 10994551
    [Abstract] [Full Text] [Related]

  • 3. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
    Schulte JH, Kuhfittig-Kulle S, Klein-Hitpass L, Schramm A, Biard DS, Pfeiffer P, Eggert A.
    DNA Repair (Amst); 2008 Oct 01; 7(10):1757-64. PubMed ID: 18678285
    [Abstract] [Full Text] [Related]

  • 4. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
    Jaboin J, Kim CJ, Kaplan DR, Thiele CJ.
    Cancer Res; 2002 Nov 15; 62(22):6756-63. PubMed ID: 12438277
    [Abstract] [Full Text] [Related]

  • 5. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
    Schulte JH, Schramm A, Klein-Hitpass L, Klenk M, Wessels H, Hauffa BP, Eils J, Eils R, Brodeur GM, Schweigerer L, Havers W, Eggert A.
    Oncogene; 2005 Jan 06; 24(1):165-77. PubMed ID: 15637590
    [Abstract] [Full Text] [Related]

  • 6. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
    Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ.
    Cancer Res; 1995 Apr 15; 55(8):1798-806. PubMed ID: 7712490
    [Abstract] [Full Text] [Related]

  • 7. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
    Zhang JH, Li AM, Chen S, Tong HX, Zhang KR, Zhang JH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb 15; 10(1):47-50. PubMed ID: 18289471
    [Abstract] [Full Text] [Related]

  • 8. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
    Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, Camoratto AM, Evans AE, Brodeur GM.
    Cancer Res; 2002 Nov 15; 62(22):6462-6. PubMed ID: 12438236
    [Abstract] [Full Text] [Related]

  • 9. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
    Eggert A, Grotzer MA, Ikegaki N, Liu XG, Evans AE, Brodeur GM.
    Cancer Res; 2002 Mar 15; 62(6):1802-8. PubMed ID: 11912158
    [Abstract] [Full Text] [Related]

  • 10. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
    Scala S, Wosikowski K, Giannakakou P, Valle P, Biedler JL, Spengler BA, Lucarelli E, Bates SE, Thiele CJ.
    Cancer Res; 1996 Aug 15; 56(16):3737-42. PubMed ID: 8706017
    [Abstract] [Full Text] [Related]

  • 11. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.
    Evans AE, Kisselbach KD, Liu X, Eggert A, Ikegaki N, Camoratto AM, Dionne C, Brodeur GM.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):181-4. PubMed ID: 11464878
    [Abstract] [Full Text] [Related]

  • 12. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
    Hecht M, Schulte JH, Eggert A, Wilting J, Schweigerer L.
    Carcinogenesis; 2005 Dec 15; 26(12):2105-15. PubMed ID: 16051641
    [Abstract] [Full Text] [Related]

  • 13. [Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study].
    Eggert A, Grotzer MA, Zhao H, Brodeur GM, Evans AE.
    Klin Padiatr; 2001 Dec 15; 213(4):191-6. PubMed ID: 11528553
    [Abstract] [Full Text] [Related]

  • 14. Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor.
    Serres F, Carney SL.
    Brain Res; 2006 Jul 26; 1101(1):36-42. PubMed ID: 16790237
    [Abstract] [Full Text] [Related]

  • 15. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
    Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt Vv, Sieverts H, Kuhfittig-Kulle S, Pfeiffer P, Versteeg R, Eggert A.
    Cancer Lett; 2005 Oct 18; 228(1-2):143-53. PubMed ID: 15921851
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
    Festuccia C, Muzi P, Gravina GL, Millimaggi D, Speca S, Dolo V, Ricevuto E, Vicentini C, Bologna M.
    Int J Oncol; 2007 Jan 18; 30(1):193-200. PubMed ID: 17143529
    [Abstract] [Full Text] [Related]

  • 17. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
    Stephan H, Zakrzewski JL, Bölöni R, Grasemann C, Lohmann DR, Eggert A.
    Pediatr Blood Cancer; 2008 Feb 18; 50(2):218-22. PubMed ID: 17973327
    [Abstract] [Full Text] [Related]

  • 18. Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex.
    Pillai A, Veeranan-Karmegam R, Dhandapani KM, Mahadik SP.
    J Neurochem; 2008 Nov 18; 107(4):941-51. PubMed ID: 18786174
    [Abstract] [Full Text] [Related]

  • 19. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells.
    Kim CJ, Matsuo T, Lee KH, Thiele CJ.
    Am J Pathol; 1999 Nov 18; 155(5):1661-70. PubMed ID: 10550322
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.
    Au CW, Siu MK, Liao X, Wong ES, Ngan HY, Tam KF, Chan DC, Chan QK, Cheung AN.
    Cancer Lett; 2009 Aug 28; 281(2):151-61. PubMed ID: 19307055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.